Member Info for RichKen

Snipet from todays news:
"South Africa - Opencast mines can return to 100% of capacity from 1st of May

Opencast mines are permitted to return in phases to 100% operation from the beginning of next month, however underground mines must continue at 50% of capacity according to the country's Trade and Industry Minister.
The country is easing from the current Level 5 lockdown stage of Level 4, which allows more workers to return to work in batches, whilst opencast miners will be able to return in larger numbers.
The Level 5 lockdown means that only essential services are allowed to work, however under Level 4, economic activities would be added with more than 1.5m South Africans able to go back to the workplace. "

https://www.uploadlibrary.com/SPAngel_JohnMeyer/SP_Angel_-_Morning_View_-_Wednesday_29.04.20.pdf

Cheers, RK

Having had a morning tree shake looks like we are heading back up again? 101, 102 seems the current floor potential to bounce towards 120 today, but if we looked at EW we might be somewhat higher than that number on the next rise (according to Mr Elliot). I am sure a few of you will be crunching the numbers!

A little quiet here today. I see the focus is in other Covid19 stocks at the moment. However, once this has the news behind it they will all be back like headless chickens!

Not sure we will be waiting too long till we hear an update from Alastair Smith on the work underway with Cytiva.

Cheers, RK

So folks, we didn’t open at 1:10!
The information portrayed on the board needs to be more accurate.
You need to be careful what is said with respect to after hours purchases. The timings can be misleading!
Still very optimistic that a £1.20 finish is more than possible.
Cheers RK

Hargreaves and Lansdown are also excellent.
But, when you invest use an investment ISA so you don’t pay tax on you gains. You can add up to £20k per year (gains are not limited) but you can only add £20k per year.
Alternatively for long term pension savings open a SIPP and the government will add 25% to what ever you put in! But you cannot access this money till you retire.
In both these tools you can buy shares, funds, investment trusts or hold cash.
Hope this helps.
Cheers RK

Morning everyone,
ERV1, I think £1.20 would be a fine target price for close of today, based on no news.
I think as people’s research illuminates their confidence and people gain a hold on this technology here the valuation realisations become more and more real.
In respect to the higher valuations, these have nothing to do with Covid19 but the potential of unlocking targeted precision cancer treatments. This if implemented will bring the valuations of higher numbers into focus. They will be such a step change in the world of oncology.
Cheers RK

The question is with this crossing trade (could be an inter MM transfer), is this so they can actually open the market down which is to spook investors that it is dropping when in fact it will be where it left off?

Either way, if we have an RNS in the morning at 7am, it will be irrelevant!

I agree with those who like a steady rise, this is important and it shows that this is heading in the right direction with huge confidence from investors that they are gradually building strong holdings (maybe off other spikes or selling other stocks into the rise which is solid day by day.

The evidence is strong that there will be a new revolutionary Antigen simple test coming to the market from a yet unannounced supplier which will change the world and get life back to a sense of normality! Investors here have a jolly good idea who this partnership is and the affirmer technology is founded with Avacta.

Investors which foresight also can see that the pre-CISION (trademarked) cancer treatment is going to be a highly valuable asset to this business and could be not only a revolution in the chemotherapy treatments in oncology departments in hospitals around the world but it is going to be a hugely valuable income to Avatca which will take this company from an innovator to a full-on Biotech Business worth billions! This is why savvy investors are coming on board as well as high net worth individuals.
Initial target price is circa £2 per share, then circa £5 per share and within 2 years £20 per share plus and a place on the FTSE250 or even the FTSE100.
Very few have such huge potential in such a short time.
Any holding here you have acquired is going to be very valuable within 2 years!
This is not advice, but my researched opinion, backed up with a strong holding!
Cheers, RK

I think the MM's are masking the actual buys below the mid-price as the spread was very tight!
Cheers, RK

Another 4667 shares at 107.0 not live!

Thanks! This is a very nice oppertunity! If we get an RNS in the morning we will see a strong appreciation of the share price!

Cheers RK

D9Ber1, we are getting closer to that crucial RNS and the opportunity to supply these super-accurate Affirmer diagnostics to Cytiva ready for global testing at speed with no pain and no need for a lab. Finally, the world will have an opportunity to progress back to normality and business and life can return to a level of normality again!
The bid is rising nicely again! This is very nicely poised for a strong afternoon. £1.15 to £1.18 finish is looking very possible!
Cheers, RK

Ferkirtrader - this is it! In now or left behind! (no advice only an opinion!).
Cheers RK

Last looked at 110/111!
Looking like a finish at around £1:15 - I think we can leave with this kind of daily rise as we head towards the £2. The price is pushing on and on!
Anyone feeling slightly happy?
This company will deliver!
Cheers RK

Ok ;-)) - Gone blue !!

Are we smelling a very encouraging RNS about to drop?

Perfect, the man on his bike goes over the handlebars again, hope he has concussion! ;-)
Then we turn blue.
The day is good!
Cheers RK

Great progress this morning, I have had a number of small buys totally just over £8K. All in the £1.01 to £1.299.

I am starting to think these prices will not be around for much longer and we will be buying in the £2 plus by the end of next week.

Given the global sales potential of our product and the months ahead, where demand will continue on there is unlikely to be another fast-growing Biotech tech business with so much upside coming behind us. Especially with some much potential in key medical breakthroughs!

Might consider top slicing towards the end of 2020! But this will produce a strong revenue stream throughout Q2, Q3 and Q4 into 2021 and I would be very surprised if a dividend will not be forthcoming in 2021.

Exciting times ahead!

Cheers, RK

A new day. We start with a £1.00 in the box on our posts.
Today’s finish likely in the £1.10 to £1.20 window.
With news of significance those numbers will be history.
I hope everyone has a great day and keep safe!
Cheers RK

Depending on if we reach £2 by the 6th May, you might say it is a good entry point. We may still have a few dips tomorrow. But we could equally open up higher. If you are going to be here a year, this is a fantastic opportunity to buy in!
Welcome FekirTrader! Another Bushy along to the Avacta story!
Cheers RK

NCYT, is fully established it has a global supply chain into over 80 countries in the world producing one of the most accurate PCR tests that are available. It is established and doing a fine job. But only can be used in hospitals and medical labs.
96 tests every 2 hours.
AVCT is a revolutionary product which will prove to be as accurate as a PCR test, using Affirmer technology for a point of care test, which anyone can check if they have Covid19. It can be used anywhere and by anyone. It will be a very low cost and give a result in minutes. It will be sold in billions of units.
This is about to go to market!
This may help you see which has the most potential!
Also, Avacta have revolutionary cancer treatments for chemotherapy and stem cell technology which can aid the treatment of Crohn's, MS and many other almost impossible to treat medical issues.
Now when are you buying into Avacta.... (Not advice just my opinion!)
Cheers, RK

There is no doubt, that with Lago about to be free of Glencore, they will be able to chose the clinet sthey want to work with and the best markets for there vanadium. We already have this freedom and with the enrgu storage market likely to really move on a step once the Covid19 situation is finally behind us we are bets plced to take this growing market into our contraol. The vertically integrated dream is at or close to reality depending on how you read it. One of the largest VRFB installations in the world looks to be making speedy progress and we have our own East London Vanadium Electrolyte plant surely will be well on its way this year.
With all that is going on it is easy to lose track of what is already achieved and where we are heading.
Our Q1 full company update is soon to be released and the nuggets of information likely to come out will give this company a solid boost and with that should come a recovery in SP to somewhere closer to where we should be.
In the last months since the start of Covid19, we have seen reports of the multitudes of people affect ed ad people sadly losing their lives, but actually the number of births will heavily outnumber the number of deaths. This is just a global situation. That means more buildings, more infrastructure and more energy requirements. Our supply chain needs vanadium for strengthening steel and vanadium for safe energy storage to work in conjunction with the growing need to renewable energy, reduced number of gas peaker plants and ensuring we have the energy and power close to the places where it is needed.
We are part of this supply chain and a very important part too.
The reason we all invested has not gone away and the net result will be that this company will be back to where it should be!
Have a great evening! Looking forward to that Q1 RNS.
Cheers, RK

I think this would be great news for the long term increase in the share price!

This means the trades are automatic with very tight spreads and a buy is a buy and a sell is a sell with no market maker masking where the SP is going.

Very few fund managers will invest in AIM-listed shares and those that do are playing a difficult game.

If this company reaches in 2020 a significant valuation it should definitely consider the move. It will need to if it wanted to be listed on multiple exchanges around the world if it is going to be a global Biotech business.

Stamp duty will hardly be an issue if your shares are suddenly trading at a price in excess of £10 per share! Not many AIM traders buy FTSE companies. But pension funds do and they hold huge amounts and the SP is then market-driven, but real success is rewarded in large trades. Buys and sells in the millions of pounds (£'s).

If Avacta succeeds on every level it could well end up as an FTSE100 company (some way to go though!).

Cheers, RK